Literature DB >> 22459904

Use of direct thrombin inhibitor for treatment of cerebral venous thrombosis.

Sonny Fong Kwong Hon1, Ho Lun Terrance Li, Pui Wai Cheng.   

Abstract

Cerebral venous thrombosis is an uncommon condition with difficulties in diagnosis and treatment. There is limited study on the best treatment option for this disease. The mainstay of treatment remains systemic anticoagulation with a lengthy duration of warfarin, which has a troublesome unpredictable drug effect, various drug and food interactions, and an increased risk of bleeding. Recent availability of direct thrombin inhibitor provides an alternative option of systemic anticoagulation in various thromboembolism conditions. We report 2 cases of cerebral venous thrombosis treated with a direct thrombin inhibitor with good clinical and radiologic results.
Copyright © 2012 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22459904     DOI: 10.1016/j.jstrokecerebrovasdis.2012.02.004

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  3 in total

Review 1.  Cerebral venous sinus thrombosis: update on diagnosis and management.

Authors:  José M Ferro; Patrícia Canhão
Journal:  Curr Cardiol Rep       Date:  2014-09       Impact factor: 2.931

2.  Direct oral anticoagulants in treatment of cerebral venous thrombosis: a systematic review.

Authors:  Gauruv Bose; Justin Graveline; Vignan Yogendrakumar; Risa Shorr; Dean A Fergusson; Gregoire Le Gal; Jonathan Coutinho; Marcelo Mendonça; Miguel Viana-Baptista; Simon Nagel; Dar Dowlatshahi
Journal:  BMJ Open       Date:  2021-02-16       Impact factor: 2.692

3.  Bilateral jugular vein and sigmoid sinus thrombosis related to an inherited coagulopathy: an unusual presentation.

Authors:  Ozge Altıntaş; Azize Esra Gürsoy; Gözde Baran; Elnur Mehdi; Talip Asil
Journal:  Case Rep Vasc Med       Date:  2014-08-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.